Zacks Investment Research downgraded shares of Molina Healthcare Inc (NYSE:MOH) from a hold rating to a sell rating in a research report report published on Tuesday.

According to Zacks, “Molina Healthcare’s shares have underperformed the industry in last one year. The company suffers from rising medical care costs along with acute dependence on debt financing that have resulted in higher interest expenses draining the bottom line. Following its lackluster second-quarter 2017 results, the company also withdrew its 2017 guidance. It has seen the Zacks Consensus Estimate for the 2018 earnings being revised downward in last 60 days.”

MOH has been the subject of a number of other reports. ValuEngine lowered Molina Healthcare from a buy rating to a hold rating in a research report on Tuesday, July 11th. Bank of America Corporation upped their price objective on Molina Healthcare from $59.00 to $60.00 and gave the company an underperform rating in a research note on Friday, July 14th. TheStreet downgraded Molina Healthcare from a b rating to a c rating in a research note on Monday, August 7th. Mitsubishi UFJ Financial Group assumed coverage on Molina Healthcare in a research note on Thursday, September 21st. They issued a neutral rating and a $70.00 price objective for the company. Finally, BidaskClub downgraded Molina Healthcare from a strong-buy rating to a buy rating in a research note on Friday, July 28th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. Molina Healthcare has a consensus rating of Hold and an average target price of $62.25.

Molina Healthcare (MOH) traded up 0.497% during trading on Tuesday, hitting $67.705. 683,482 shares of the company traded hands. Molina Healthcare has a 12-month low of $42.56 and a 12-month high of $72.79. The stock has a 50-day moving average price of $64.39 and a 200-day moving average price of $62.04. The firm’s market capitalization is $3.87 billion.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.87). The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.88 billion. Molina Healthcare had a negative net margin of 1.07% and a positive return on equity of 16.10%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.67 earnings per share. Equities analysts expect that Molina Healthcare will post ($2.70) EPS for the current fiscal year.

WARNING: This report was published by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.watchlistnews.com/zacks-investment-research-lowers-molina-healthcare-inc-moh-to-sell/1613303.html.

In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $60.00, for a total transaction of $60,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director J Mario Md Molina sold 15,000 shares of the stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $67.73, for a total value of $1,015,950.00. The disclosure for this sale can be found here. Insiders have sold a total of 293,045 shares of company stock valued at $18,799,628 in the last quarter. 6.20% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of MOH. Great West Life Assurance Co. Can boosted its stake in Molina Healthcare by 7.2% in the 1st quarter. Great West Life Assurance Co. Can now owns 25,307 shares of the company’s stock worth $1,153,000 after purchasing an additional 1,699 shares during the period. First Trust Advisors LP boosted its stake in Molina Healthcare by 39.5% in the 1st quarter. First Trust Advisors LP now owns 46,553 shares of the company’s stock worth $2,123,000 after purchasing an additional 13,176 shares during the period. Comerica Bank boosted its stake in Molina Healthcare by 4.5% in the 1st quarter. Comerica Bank now owns 32,773 shares of the company’s stock worth $1,594,000 after purchasing an additional 1,416 shares during the period. Swiss National Bank boosted its stake in Molina Healthcare by 1.4% in the 1st quarter. Swiss National Bank now owns 65,500 shares of the company’s stock worth $2,987,000 after purchasing an additional 900 shares during the period. Finally, Karp Capital Management Corp bought a new position in Molina Healthcare in the 1st quarter worth about $699,000. Institutional investors and hedge funds own 96.04% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.